<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02788383</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-RHD-2016-18</org_study_id>
    <nct_id>NCT02788383</nct_id>
  </id_info>
  <brief_title>Fetal RhD Genotye Non Invasive Prenatal Determination</brief_title>
  <official_title>Aplicación en la práctica clínica de la determinación Prenatal no Invasiva en el Genotipo RhD Fetal Durante el Primer Trimestre de la gestación en Gestantes RhD Negativas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Actually, our center is doing the prenatal determination of RhD fetal genotype in all RhD
      negative pregnant women.

      The investigator want to demonstrate that this is an useful and efficient method.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective observational study that pretend to demonstrate that the prenatal
      determination of RhD fetal genotype is useful and efficient in our clinical practice.

      I'm going to check the clinical history of all negative RhD pregnant women since January 2013
      until December 2015.

      I'll check if prenatal determination matches with postnatal RhD determination of newborn.

      Usually, when a RhD negative woman is pregnant we administrate gammaglobulin in 28 gestation
      weeks, after invasive procedures and after delivery if the baby is positive RhD.

      Althought, the investigators know that the 40 percent of RhD negative pregnant have a
      negative RhD baby.

      This study will do posible to know how many gammaglobulins hasn't been necessary thanks to
      prenatal determination.

      This is an important thing because gammaglobulin is an humanoid product ( it isn't without
      heatlth risks,...) and because is expensive.

      For this reason, if the investigators do universal determination of RhD fetal genotype the
      investigators can avoid the administration of humanoid product in pregnant women.

      I want to demonstrate that this practice is very useful and efficient in our population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prenatal determination fetal RhD genotype</measure>
    <time_frame>Ten months</time_frame>
    <description>RhD negative/ RhD positive</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pregnant Women</condition>
  <condition>Rh-Hr Blood-Group System</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant RhD negative women since January 2013 until December 2015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant RhD negative women

        Exclusion Criteria:

          -  Pregnant RhD positive women
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Obdulia Alejos, MD</last_name>
    <phone>+34935565760</phone>
    <email>oalejos@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Obdulia Alejos, MD</last_name>
      <email>oalejos@santpau.cat</email>
    </contact>
    <investigator>
      <last_name>Obdulia Alejos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>May 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <last_update_submitted>June 20, 2016</last_update_submitted>
  <last_update_submitted_qc>June 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

